Found Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.6/10
Best for: tirzepatide at $169/month, 37% below the typical price
Found's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Prices checked August 2026
Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.
Is Found legit?
Yes. Found is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 8.6/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Found promo or coupon code?
Found has no code to type in. The current offer: the 3-Month Kickstart makes your first month of the program subscription free (then about $129/mo). It applies at checkout on its own. Coupon sites advertising a "Found promo code" are not a source we can vouch for.
See how Found compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Found at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo
- What's included
- Medication · Consult · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How Found scores
Six columns, each one computed from something Found has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.8/10$169/month is 32% below the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses orforglipron, semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves 50 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Found
Last checked August 2026- Checked the listed price across 7 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Found
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Found involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Found shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Found which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and coaching.
- Lowest ongoing monthly price: tirzepatide $169. That leaves out membership fees, first-month rates and insurance copays.
- Found serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling Found
Taken from the terms Found publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Not published by the seller
GLP-1 medications Found offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
$169/mo cash-pay on the 12-month prepaid plan, with medication, membership and coaching included; $99/mo with insurance on the same 12-month prepaid plan. Month-to-month: $199/mo with insurance, $289/mo cash. A '$100 off today' promo was running at checkout.
Same Compounded GLP-1 Plan price as semaglutide, with no per-drug price published; the drug and price are set after intake. Cash: $169/mo prepaid for 12 months or $289/mo month to month. Insurance: $99/mo prepaid.
Starting cash price of about $149/mo, listed on Found's Foundayo comparison table. Newly added to Found's menu.
Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.
Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.
Brand-name Ozempic at $1,100/mo, as advertised on the homepage.
Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.
Check the price yourself before you pay
Every figure here was read off Found's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $169 a month, 32% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Found
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Found charges
Found charges $149/month.
- Compounded semaglutide with insurance: $99 first month, then $169/month
- Compounded tirzepatide with insurance: $99 first month, then $169/month
- Oral orforglipron (foundayo): $149/month
- Brand-name semaglutide (wegovy): $650/month
- Brand-name tirzepatide (zepbound): $650/month
- Brand-name semaglutide (ozempic): $1,100/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so Found's $169 is genuinely below the middle, not just advertised that way.
Gala, at about $149/month, is the closest like-for-like alternative we review.
What Found dispenses
Found prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Found at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Found tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. It also offers coaching as part of the plan. We found no FDA warning letters issued to Found. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Found will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Found bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- injections are the thing keeping you from starting
- you want coaching bundled in rather than billed on top
- you need access wherever you live
Our read
Found competes on price without an obvious sacrifice elsewhere: $169/month for compounded tirzepatide, no FDA warning letters, and wide state coverage.
The Bottom Line
Found's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay Found
Starting at $149 a month. Check today's price, then start the intake.
Alternatives to Found
Editorial score · methodology
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Compare Found head to head
The sellers closest to Found on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Found review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Found's current pricing
Plans start at $149 a month. Whether you qualify is a clinician's decision, made after your intake.